Solid State Changes in Active Pharmaceutical Ingredients: Improvements, Challenges, and Prospects
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: closed (20 July 2022) | Viewed by 316
Special Issue Editors
Interests: lipid-based carriers; drug delivery systems; in vivo assays; clinical assays
Special Issues, Collections and Topics in MDPI journals
Interests: thermal analysis; solid-state; drug design; physiscal-chemical characterization; nanotechnology
Interests: thermal analysis; solid-state; drug design; physiscal-chemical characterization; nanotechnology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The screening of new solid-state forms involving orally administered APIs has been growing in recent decades because the changes in physical–chemical parameters are strategies that can create benefits that go beyond an increase in bioavailability and have a relatively low cost when compared with the development of new drugs. The solid-state approach includes salts, solvates, polymorphs, eutectics, amorphous and co-amorphous phases, cocrystals, etc., each with their particularities and advantages.
Recognizing the emerging trends in this field, we would like to invite you to contribute a short communication, full article, or review to this Special Issue, titled: “Solid State Changes in Active Pharmaceutical Ingredients: Improvements, Challenges and Prospects.”. This Special Issue deals with different aspects related to solid-state changes in drugs and will include articles describing the discovery and preparation, characterization, enhancement of APIs, and their latest developments.
Dr. Marlus Chorilli
Dr. Flávio Junior Caires
Dr. André Luiz Carneiro S. Nascimento
Dr. Richard Perosa Fernandes
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- solid state
- pharmaceutical APIs
- solid forms
- drug Improvement
- bioavailability
